Up&Up loratadine orally disintegrating tablets
Superpotent Drug: Out Of Specification (OOS) result for Assay.
1,525 recalls · Class III, newest first
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Superpotent Drug: Out Of Specification (OOS) result for Assay.
Failed Dissolution Specifications
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station
Failed Tablet/Capsule Specifications; report of oversized and discolored tablets
Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.
Chemical Contamination; benzophenone leached from the product label varnish
Chemical Contamination; benzophenone leached from the product label varnish